These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 21762686)

  • 1. Discriminative stimulus properties of GABAA receptor positive allosteric modulators TPA023, ocinaplon and NG2-73 in rats trained to discriminate chlordiazepoxide or zolpidem.
    Vinkers CH; Olivier B; Hanania T; Min W; Schreiber R; Hopkins SC; Campbell U; Paterson N
    Eur J Pharmacol; 2011 Oct; 668(1-2):190-3. PubMed ID: 21762686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative cue generalization profiles of L-838, 417, SL651498, zolpidem, CL218,872, ocinaplon, bretazenil, zopiclone, and various benzodiazepines in chlordiazepoxide and zolpidem drug discrimination.
    Mirza NR; Rodgers RJ; Mathiasen LS
    J Pharmacol Exp Ther; 2006 Mar; 316(3):1291-9. PubMed ID: 16339395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel discriminative stimulus effects of TPA023B, subtype-selective gamma-aminobutyric-acid(A)/benzodiazepine modulator: comparisons with zolpidem, lorazepam, and TPA023.
    Kohut SJ; Ator NA
    Pharmacol Biochem Behav; 2008 Jul; 90(1):65-73. PubMed ID: 18395780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strain- and model-dependent effects of chlordiazepoxide, L-838,417 and zolpidem on anxiety-like behaviours in laboratory mice.
    Mathiasen LS; Mirza NR; Rodgers RJ
    Pharmacol Biochem Behav; 2008 Jul; 90(1):19-36. PubMed ID: 18321566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects.
    Depoortere H; Zivkovic B; Lloyd KG; Sanger DJ; Perrault G; Langer SZ; Bartholini G
    J Pharmacol Exp Ther; 1986 May; 237(2):649-58. PubMed ID: 2871178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GABA(A) receptor α subunits differentially contribute to diazepam tolerance after chronic treatment.
    Vinkers CH; van Oorschot R; Nielsen EØ; Cook JM; Hansen HH; Groenink L; Olivier B; Mirza NR
    PLoS One; 2012; 7(8):e43054. PubMed ID: 22912786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug discrimination analysis of midazolam under a three-lever procedure. II: Differential effects of benzodiazepine receptor agonists.
    Sannerud CA; Ator NA
    J Pharmacol Exp Ther; 1995 Oct; 275(1):183-93. PubMed ID: 7562548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discriminative stimulus effects of zolpidem in squirrel monkeys: role of GABA(A)/alpha1 receptors.
    Rowlett JK; Spealman RD; Lelas S; Cook JM; Yin W
    Psychopharmacology (Berl); 2003 Jan; 165(3):209-15. PubMed ID: 12420154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminative stimulus effects of zolpidem in squirrel monkeys: comparison with conventional benzodiazepines and sedative-hypnotics.
    Rowlett JK; Spealman RD; Lelas S
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1233-41. PubMed ID: 10565847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of intraseptal zolpidem and chlordiazepoxide on spatial working memory and high-affinity choline uptake in the hippocampus.
    Herzog CD; Gandhi C; Bhattacharya P; Walsh TJ
    Neurobiol Learn Mem; 2000 Mar; 73(2):168-79. PubMed ID: 10704326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of chlordiazepoxide, bretazenil, L838,417 and zolpidem in a validated mouse Vogel conflict test.
    Mathiasen L; Mirza NR
    Psychopharmacology (Berl); 2005 Nov; 182(4):475-84. PubMed ID: 16133136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Native gamma-aminobutyric acid type A receptors from rat hippocampus, containing both alpha 1 and alpha 5 subunits, exhibit a single benzodiazepine binding site with alpha 5 pharmacological properties.
    Araujo F; Ruano D; Vitorica J
    J Pharmacol Exp Ther; 1999 Sep; 290(3):989-97. PubMed ID: 10454469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective anxiolysis produced by ocinaplon, a GABA(A) receptor modulator.
    Lippa A; Czobor P; Stark J; Beer B; Kostakis E; Gravielle M; Bandyopadhyay S; Russek SJ; Gibbs TT; Farb DH; Skolnick P
    Proc Natl Acad Sci U S A; 2005 May; 102(20):7380-5. PubMed ID: 15870187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anxioselective agent 7-(2-chloropyridin-4-yl)pyrazolo-[1,5-a]-pyrimidin-3-yl](pyridin-2-yl)methanone (DOV 51892) is more efficacious than diazepam at enhancing GABA-gated currents at alpha1 subunit-containing GABAA receptors.
    Popik P; Kostakis E; Krawczyk M; Nowak G; Szewczyk B; Krieter P; Chen Z; Russek SJ; Gibbs TT; Farb DH; Skolnick P; Lippa AS; Basile AS
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1244-52. PubMed ID: 16971504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further investigation of the stimulus properties of chlordiazepoxide and zolpidem. Agonism and antagonism by two novel benzodiazepines.
    Sanger DJ
    Psychopharmacology (Berl); 1987; 93(3):365-8. PubMed ID: 2829266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TPA023 [7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine], an agonist selective for alpha2- and alpha3-containing GABAA receptors, is a nonsedating anxiolytic in rodents and primates.
    Atack JR; Wafford KA; Tye SJ; Cook SM; Sohal B; Pike A; Sur C; Melillo D; Bristow L; Bromidge F; Ragan I; Kerby J; Street L; Carling R; Castro JL; Whiting P; Dawson GR; McKernan RM
    J Pharmacol Exp Ther; 2006 Jan; 316(1):410-22. PubMed ID: 16183706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the novel subtype-selective GABAA receptor-positive allosteric modulator NS11394 [3'-[5-(1-hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile] with diazepam, zolpidem, bretazenil, and gaboxadol in rat models of inflammatory and neuropathic pain.
    Munro G; Lopez-Garcia JA; Rivera-Arconada I; Erichsen HK; Nielsen EØ; Larsen JS; Ahring PK; Mirza NR
    J Pharmacol Exp Ther; 2008 Dec; 327(3):969-81. PubMed ID: 18791060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited central side effects of a β-subunit subtype-selective GABAA receptor allosteric modulator.
    Yoshimura RF; Tran MB; Hogenkamp DJ; Johnstone TB; Xie JY; Porreca F; Gee KW
    J Psychopharmacol; 2014 May; 28(5):472-8. PubMed ID: 24108410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: I. Comparison with triazolam in rhesus monkeys and rats.
    Rowlett JK; Woolverton WL
    J Pharmacol Exp Ther; 1997 Jan; 280(1):162-73. PubMed ID: 8996194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NS11394 [3'-[5-(1-hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile], a unique subtype-selective GABAA receptor positive allosteric modulator: in vitro actions, pharmacokinetic properties and in vivo anxiolytic efficacy.
    Mirza NR; Larsen JS; Mathiasen C; Jacobsen TA; Munro G; Erichsen HK; Nielsen AN; Troelsen KB; Nielsen EØ; Ahring PK
    J Pharmacol Exp Ther; 2008 Dec; 327(3):954-68. PubMed ID: 18791063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.